Precision BioSciences's total assets for Q4 2025 were $154.42M, an increase of 65.13% from the previous quarter. DTIL total liabilities were $62.17M for the fiscal quarter, a -19.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.